¼¼°èÀÇ µðÁöÅÐ Áø´Ü ½ÃÀå
Digital Diagnostics
»óǰÄÚµå : 1797246
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 384 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,215,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,647,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ µðÁöÅÐ Áø´Ü ½ÃÀåÀº 2030³â±îÁö 31¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 12¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ µðÁöÅÐ Áø´Ü ½ÃÀåÀº 2024-2030³â¿¡ CAGR 18.0%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 31¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ Çϵå¿þ¾î ÄÄÆ÷³ÍÆ®´Â CAGR 17.5%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 18¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ÄÄÆ÷³ÍÆ® ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 19.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3¾ï 1,560¸¸ ´Þ·¯, Áß±¹Àº CAGR 23.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ µðÁöÅÐ Áø´Ü ½ÃÀåÀº 2024³â¿¡ 3¾ï 1,560¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 6¾ï 9,310¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£2024-2030³â CAGRÀº 23.6%°¡ µË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 13.4%¿Í 16.2%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 14.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ µðÁöÅÐ Áø´Ü ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

µðÁöÅÐ Áø´ÜÀÌ ÀÓ»ó °Ë»ç ¹× ¸ð´ÏÅ͸µÀ» ¾î¶»°Ô º¯È­½Ãų °ÍÀΰ¡?

µðÁöÅÐ Áø´ÜÀº ÀÇ·á °Ë»ç ±â¼ú°ú µðÁöÅÐ Ç÷§ÆûÀ» °áÇÕÇÏ¿© Áúº´ ¹ß°ß, ȯÀÚ ¸ð´ÏÅ͸µ, ÀÇ»ç°áÁ¤À» °³¼±ÇÕ´Ï´Ù. µðÁöÅÐ Áø´ÜÀº ¿¬°áµÈ ÀåÄ¡¿Í ¼ÒÇÁÆ®¿þ¾î¸¦ ÅëÇØ ½Å¼ÓÇÏ°í ºÐ»êµÈ °Ë»ç¸¦ °¡´ÉÇÏ°Ô Çϰí, ÀÇ·á Àü¹®°¡°¡ ¿ø°ÝÀ¸·Î °á°ú¸¦ ºÐ¼®ÇÏ°í ½Ç½Ã°£À¸·Î ÀλçÀÌÆ®¸¦ °øÀ¯ÇÒ ¼ö ÀÖ°Ô ÇÕ´Ï´Ù. ¿ëµµ´Â ¸¸¼ºÁúȯ ¸ð´ÏÅ͸µ, °¨¿°¼º Áúȯ °Ë»ç, À¯ÀüÀÚ °Ë»ç, ¿ø°Ý º´¸® °Ë»ç¿¡ À̸£±â±îÁö ´Ù¾çÇÕ´Ï´Ù.

µðÁöÅÐ ½Ã½ºÅÛÀ» ÅëÇØ ¼öÁýµÈ Áø´Ü µ¥ÀÌÅÍ´Â ÀÚµ¿À¸·Î ÀúÀå, ºÐ¼®µÇ°í, ¸¹Àº °æ¿ì ÀüÀڰǰ­±â·Ï¿¡ ÅëÇյ˴ϴÙ. À̸¦ ÅëÇØ Àϰü¼ºÀ» ³ôÀ̰í Áø´Ü ¿À·ù¸¦ ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀçÅà °Ë»ç ŰƮ, ½º¸¶Æ®Æù °Ë»ç, ¿þ¾î·¯ºí °Ç°­ ¸ð´ÏÅʹ ȯÀÚ¿¡°Ô ½Ç½Ã°£ Çǵå¹éÀ» Á¦°øÇÏ°í º´¿ø ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãä´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº Áö¹æÀÇ ÀÇ·á ¼­ºñ½º Á¦°ø°ú ÆÒµ¥¹Í ´ëÀÀ °èȹ¿¡µµ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¾î¶² ±â¼úÀÌ µðÁöÅÐ Áø´Ü ´É·ÂÀ» Çâ»ó½Ã۰í Àִ°¡?

¹ÙÀÌ¿À¼¾¼­ ¼³°è, ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º°øÇÐ, ¼ÒÇüÈ­ÀÇ ¹ßÀüÀ¸·Î ½ÇÇè½Ç ¼öÁØÀÇ Á¤¹Ðµµ¸¦ ±¸ÇöÇÏ´Â ÈÞ´ë¿ë Áø´Ü Àåºñ°¡ °¡´ÉÇØÁ³½À´Ï´Ù. ºí·çÅõ½º, Wi-Fi, Ŭ¶ó¿ìµå ½Ã½ºÅÛÀ» ÅëÇÑ ¿¬°á¼ºÀ¸·Î µð¹ÙÀ̽º¿Í ÇコÄɾî Ç÷§Æû °£ÀÇ Áö¼ÓÀûÀÎ µ¥ÀÌÅÍ Àü¼ÛÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. AI ¾Ë°í¸®ÁòÀº ¹æ»ç¼±ÇÐ, º´¸®ÇÐ, ÇǺΰúÇÐÀÇ ÆÐÅÏ ÀνĿ¡ »ç¿ëµÇ¾î Áø´Ü ¼Óµµ¿Í Á¤È®µµ¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

ºÐÀÚÁø´ÜÇÐÀº µðÁöÅÐ PCR ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀ¸·Î ÁøÈ­Çϰí ÀÖÀ¸¸ç, Àú³óµµ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ¹Î°¨µµ°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¸Ó½Å·¯´×Àº °³ÀÎÈ­µÈ Áúº´ ÇÁ·ÎÆÄÀϸµÀ» À§ÇÑ À¯Àüü ¹× ´Ü¹éÁúüÇÐ µ¥ÀÌÅÍ ºÐ¼®¿¡µµ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ º¸¾È ¹× ¾Ïȣȭ ÇÁ·¹ÀÓ¿öÅ©´Â Ç÷§Æû °£ ȯÀÚ µ¥ÀÌÅÍÀÇ ¾ÈÀüÇÑ ÀúÀå ¹× °øÀ¯¸¦ º¸ÀåÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úµéÀº ÃÑüÀûÀ¸·Î Á¶±â ¹ß°ß, ºü¸¥ °á°ú, °³¼±µÈ Ä¡·á °æ·Î·ÎÀÇ ÀüȯÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

µðÁöÅÐ Áø´Ü ÅøÀÇ µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ´Â °÷Àº ¾îµðÀΰ¡?

º´¿ø°ú Áø´Ü°Ë»ç½ÇÀº ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÏ°í ´õ ¸¹Àº °Ë»ç·®À» °ü¸®Çϱâ À§ÇØ µðÁöÅÐ ¼Ö·ç¼ÇÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. 1Â÷ Áø·á¼Ò¿¡¼­´Â Áø´Ü ½Ã°£À» ´ÜÃàÇϰí ȯÀÚ ºÐ·ù¸¦ °³¼±Çϱâ À§ÇØ ½Å¼Ó Áø´Ü ÅøÀ» »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, È£Èí±â ÁúȯÀ» À§ÇÑ ÀçÅà Áø´Ü ŰƮ´Â °í·ÉÈ­ »çȸ¿Í °Åµ¿ÀÌ ºÒÆíÇÑ È¯ÀÚµé »çÀÌ¿¡¼­ ¼ö¿ëµÇ°í ÀÖ½À´Ï´Ù.

Á¦¾àȸ»ç¿Í ÀÓ»ó½ÃÇè ¿î¿µÀÚ´Â µðÁöÅÐ Áø´ÜÀ» ÅëÇÕÇÏ¿© ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ°ú ½Ç½Ã°£ µ¥ÀÌÅÍ ¼öÁýÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. °øÁß º¸°Ç ´ç±¹Àº Áúº´ ¹ß»ý½Ã ¸ð¹ÙÀÏ Áø´Ü ÀåÄ¡¿Í µðÁöÅÐ ¸ð´ÏÅ͸µ ÅøÀ» ¹èÄ¡Çϰí ÀÖ½À´Ï´Ù. ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æ¿¡¼­´Â µðÁöÅÐ Áø´Ü Ç÷§ÆûÀÌ Áö¿ª º¸°Ç¼Ò³ª ¿Üµý ¸¶À»¿¡¼­ ±âº»ÀûÀÎ °Ë»ç¸¦ °¡´ÉÇÏ°Ô ÇÏ¿© Á¢±Ù¼º°ú ÇüÆò¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

µðÁöÅÐ Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

µðÁöÅÐ Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀº ÀÇ·á ¼­ºñ½º Á¦°ø ¸ðµ¨, ±â¼ú ¹ßÀü, Àα¸ Åë°èÇÐÀû ¿äÀÎ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯ ¹× °¨¿°¼º ÁúȯÀÇ Á¶±â ¹× Á¤È®ÇÑ Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÈÞ´ë¿ë ¹× Ä¿³ØÆ¼µå °Ë»ç ½Ã½ºÅÛÀÇ µµÀÔÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ºÐ»êÇü Äɾî¿Í ¿ø°Ý °Ç°­ ¸ð´ÏÅ͸µÀ¸·ÎÀÇ ÀüȯÀº ÀçÅà ¹× ¸ð¹ÙÀÏ Áø´Ü Åø¿¡ ´ëÇÑ °­·ÂÇÑ ½ÃÀåÀ» âÃâÇß½À´Ï´Ù.

ÀÇ·á ±â·ÏÀÇ µðÁöÅÐÈ­ ¹× »óÈ£¿î¿ë¼º Àǹ«È­´Â Áø´Ü µ¥ÀÌÅ͸¦ ȯÀÚ °ü¸® Ç÷§Æû¿¡ ÅëÇÕÇÏ´Â °ÍÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼¾¼­ÀÇ Á¤È®¼º, ±â±âÀÇ È޴뼺, AI ±â¹Ý ºÐ¼®ÀÇ Áö¼ÓÀûÀÎ Çõ½ÅÀº Áø´ÜÀÇ ½Å·Ú¼ºÀ» Áö¼ÓÀûÀ¸·Î Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. Áö¿øÀûÀÎ »óȯ Á¤Ã¥°ú µðÁöÅÐ Çコ ÀÎÇÁ¶ó¿¡ ´ëÇÑ Á¤ºÎ ÅõÀÚ´Â º¸´Ù ±¤¹üÀ§ÇÑ Á¢±ÙÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ °¡Ä¡ ±â¹Ý Áø·á·Î ÀüȯÇÏ´Â °¡¿îµ¥, µðÁöÅÐ Áø´ÜÀº ´Ù¾çÇÑ ÀÓ»ó ÇöÀå¿¡¼­ È¿À²¼º, ȯÀÚ Âü¿©, °á°ú ÃßÀû¿¡ ´ëÇÑ ÃøÁ¤ °¡´ÉÇÑ °³¼±À» Á¦°øÇÕ´Ï´Ù.

ºÎ¹®

ÄÄÆ÷³ÍÆ®(Çϵå¿þ¾î ÄÄÆ÷³ÍÆ®, ¼ÒÇÁÆ®¿þ¾î ÄÄÆ÷³ÍÆ®, ¼­ºñ½º ÄÄÆ÷³ÍÆ®); Áø´Ü À¯Çü(½ÉÀ庴 Áø´Ü, Á¾¾ç Áø´Ü, ½Å°æÇÐ Áø´Ü, ¹æ»ç¼±ÇÐ Áø´Ü, º´¸®ÇÐ Áø´Ü, ±âŸ Áø´Ü À¯Çü); ÃÖÁ¾»ç¿ëÀÚ(º´¿ø¡¤Áø·á¼Ò ÃÖÁ¾»ç¿ëÀÚ, ÀÓ»ó °Ë»ç ±â°ü ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Digital Diagnostics Market to Reach US$3.1 Billion by 2030

The global market for Digital Diagnostics estimated at US$1.2 Billion in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 18.0% over the analysis period 2024-2030. Hardware Component, one of the segments analyzed in the report, is expected to record a 17.5% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Software Component segment is estimated at 19.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$315.6 Million While China is Forecast to Grow at 23.6% CAGR

The Digital Diagnostics market in the U.S. is estimated at US$315.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$693.1 Million by the year 2030 trailing a CAGR of 23.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.4% and 16.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.3% CAGR.

Global Digital Diagnostics Market - Key Trends & Drivers Summarized

How Are Digital Diagnostics Transforming Clinical Testing and Monitoring?

Digital diagnostics combines medical testing technologies with digital platforms to improve disease detection, patient monitoring, and decision-making. It enables rapid, decentralized testing through connected devices and software, allowing healthcare professionals to analyze results remotely and share insights in real time. Applications range from chronic disease monitoring and infectious disease screening to genetic testing and telepathology.

Diagnostic data captured through digital systems is automatically stored, analyzed, and often integrated into electronic medical records. This improves consistency and reduces diagnostic errors. At-home testing kits, smartphone-based assays, and wearable health monitors provide patients with real-time feedback and reduce dependence on hospital infrastructure. These solutions are also instrumental in rural healthcare delivery and pandemic response planning.

Which Technologies Are Advancing Digital Diagnostics Capabilities?

Advances in biosensor design, microfluidics, and miniaturization have enabled portable diagnostic devices that deliver lab-grade accuracy. Connectivity through Bluetooth, Wi-Fi, and cloud systems allows continuous data transmission between devices and healthcare platforms. AI algorithms are used for pattern recognition in radiology, pathology, and dermatology, improving diagnostic speed and precision.

Molecular diagnostics is evolving through integration with digital PCR systems, enhancing sensitivity for low-concentration biomarkers. Machine learning is also applied to interpret genomic and proteomic data for personalized disease profiling. Data security and encryption frameworks ensure safe storage and sharing of patient data across platforms. These technologies collectively support a shift toward earlier detection, faster results, and improved care pathways.

Where Is the Adoption of Digital Diagnostic Tools Accelerating?

Hospitals and diagnostic laboratories are implementing digital solutions to streamline workflows and manage higher testing volumes. Primary care clinics use rapid diagnostic tools to reduce time to diagnosis and improve patient triage. In-home diagnostic kits for diabetes, cardiovascular conditions, and respiratory illnesses are gaining acceptance among aging populations and patients with mobility constraints.

Pharmaceutical companies and clinical trial operators are integrating digital diagnostics to enable remote patient monitoring and real-time data capture. Public health authorities deploy mobile diagnostic units and digital surveillance tools during disease outbreaks. In low-resource settings, digital diagnostic platforms enable basic testing in community health centers and remote villages, improving access and equity.

What Factors Are Driving Growth in the Digital Diagnostics Market?

Growth in the digital diagnostics market is driven by several factors related to healthcare delivery models, technology advancements, and population health trends. Rising demand for early, accurate diagnosis of chronic and infectious diseases has increased deployment of portable and connected testing systems. Shift toward decentralized care and remote health monitoring has created a strong market for home-based and mobile diagnostic tools.

Digitalization of healthcare records and interoperability mandates have supported integration of diagnostic data into patient care platforms. Ongoing innovation in sensor accuracy, device portability, and AI-driven analytics continues to improve diagnostic reliability. Supportive reimbursement policies and government investments in digital health infrastructure are facilitating broader access. As healthcare systems move toward value-based care, digital diagnostics offer measurable improvements in efficiency, patient engagement, and outcome tracking across varied clinical settings.

SCOPE OF STUDY:

The report analyzes the Digital Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Hardware Component, Software Component, Services Component); Diagnosis Type (Cardiology Diagnosis, Oncology Diagnosis, Neurology Diagnosis, Radiology Diagnosis, Pathology Diagnosis, Other Diagnosis Types); End-User (Hospitals & Clinics End-User, Clinical Laboratories End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â